PREVALENCE OF MODY IN ITALY. A MULTICENTRE STUDY
R.Lorini1. G.d'Annunzio2, A.Alibrandi2,
L.Vitali2, M.Cotellessa1, F.Barbetti3,
C.Bellannč-Chantelot4, E.Bonifacio5, C. Klersy6,
on behalf of Diabetes Study Group of the Italian Society for Pediatric
Endocrinology and Diabetology (SIEDP), 1Dip. Pediatria, Universita
di Genova, IRCCS G.Gaslini, Genova; 2Dip. Scienze
Pediatriche, Universita di Pavia, IRCCS Policlinico S.Matteo, Pavia; 3Laboratorio
di Patologia Molecolare del Diabete, IRCCS S.Raffaele, Milano; 4Fondation
Jean Dausset-CEPH, Parigi, Francia; 5Dip. di Medicina IRCCS
S.Raffaele, Milano, 6Direzione Scientifica, Unitā di Biometria,
IRCCS Policlinico S.Matteo, Pavia.
OBJECTIVE:
During childhood, an incidental hyperglycaemia can lead to a diagnosis of
maturity-onset diabetes of the young (MODY). The purpose of this study was to
assess the prevalence of MODY among subiects investigated for incidental
hyperglycaemia. METHODS: A questionary was distributed to 32 Italian
Pediatric Centers in order to report year by year from 1992 to 1998: 1) the
number of subjects screened for incidental hyperglycaemia; 2) the number of
subjects with clinical diagnosis of MODY, including familial type 2 diabetes
(consistent with an autosomal dominant inheritance) and absence of type 1
diabetes autoimmunity; 3) the number of subjects analysed for MODY genes.
RESULTS:
Among 819 subjects (520 males and 299 females, aged 1-18 years) with incidental
hyperglycaemia we found 250 subiects with clinical diagnosis of MODY, therefore
the prevalence was 30.5%. After an almost complete screening of the glucokinase
gene (MODY2) in 180 patients, 69 MODY2 mutations were found (38.3%). In
contrast, the screening of the HNF-la
gene (MODY3) of 46 families has led to the identification of only 8 MODY3 mutations
(17.4%). In 47.5% of these subjects the presence of MODY2 and MODY3 gene
mutations has been excluded.
CONCLUSIONS:
Our results underline the importance to investigate children with incidental
hyperglycaemia and familial type 2 diabetes, in order to make an early
diagnosis of MODY.